INDV Insider Trading Activity and SEC Form 4 Filings
INDV insider trading summary
Over the past 12 months, insiders at Indivior Pharmaceuticals, Inc. (INDV) reported 7 open-market purchases worth $280K by 6 insiders and 1 sale worth $707K by 1 insider on SEC Form 4. Net insider selling was $427K.
Latest INDV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 27, 2026 | Woodrow D Anderson | Chief Accounting Officer | Buy | $54K (1,500 @ $35.69) |
| Aug 5, 2026 | Woodrow D Anderson | Chief Accounting Officer | Buy | $54K (1,500 @ $36.28) |
| Jun 11, 2026 | Christian Heidbreder | Chief Scientific Officer | Sell | $707K (18,586 @ $38.06) |
| Jan 5, 2026 | Keith Humphreys | Director | Buy | $27K (775 @ $35.39) |
| Jan 5, 2026 | David E. Wheadon | Director | Buy | $63K (1,771 @ $35.39) |
| Jan 5, 2026 | Barbara Ryan | Director | Buy | $27K (775 @ $35.39) |
| Jan 5, 2026 | Mark Stejbach | Director | Buy | $27K (775 @ $35.39) |
| Jan 5, 2026 | Daniel A Ninivaggi | Director | Buy | $27K (775 @ $35.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.